Vident Advisory’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
Vident Advisory's ACLS Position: Q2 2026 in Review
Vident Advisory reduced its Axcelis (ACLS) stake by 63% in Q2 2026, selling an estimated $1.25M and leaving 5,036 shares worth $954K. The position accounts for 0.01% of the portfolio, ranked #987.
Vident Advisory first reported a position in ACLS in Q3 2023 and has held it in 11 quarters since. The position peaked at $2.47M in Q4 2024. 443 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.
- Vident Advisory held 5,036 shares of Axcelis worth $954K as of Q2 2026.
- Vident Advisory sold 8,420 Axcelis shares in Q2 2026, an estimated $1.25M.
- Axcelis made up 0.01% of Vident Advisory's portfolio in Q2 2026, its #987 holding.
- Vident Advisory first reported a position in Axcelis in Q3 2023 and has held it in 11 quarters since.
- Vident Advisory's Axcelis position peaked at $2.47M in Q4 2024.
- 443 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.
Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.